Notícias Tempest Therpeutics Inc - TPST | Ações NASDAQ | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Tempest Therpeutics Inc (TPST)
Tempest Therpeutics Inc (TPST) Notícias

Tempest Therpeutics Inc (TPST)

0,8049

0,0166

( 2,11% )

Atualizado: 15:24:18

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Form 424B5 - Prospectus [Rule 424(b)(5)]

Form EFFECT - Notice of Effectiveness

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Tempest Receives Orphan Drug Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma (HCC)

Form 8-K - Current report

Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Form 8-K - Current report

Tempest to Participate in the Piper Sandler 36th Annual Healthcare Conference

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Tempest Therpeutics

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições